Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients
Clinical trial NCT01746095 · COMPLETED
Trial details
- NCT number
- NCT01746095
- Sponsor
- Savara Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2014-11-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.